Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 7—July 2016
Synopsis

Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013–2014

Farida Ismail Al Hosani1, Kimberly Pringle1Comments to Author , Mariam Al Mulla, Lindsay Kim, Huong T. Pham, Negar N. Alami, Ahmed Khudhair, Aron J. Hall, Bashir Aden, Feda El Saleh, Wafa Al Dhaheri, Zyad Al Bandar, Sudhir Bunga, Kheir Abou Elkheir, Ying Tao, Jennifer C. Hunter, Duc T. Nguyen, Andrew Turner, Krishna Pradeep, Jurgen Sasse, Stefan Weber, Suxiang Tong, Brett L. Whitaker, Lia M. Haynes, Aaron Curns, and Susan I. Gerber
Author affiliations: Health Authority Abu Dhabi, Abu Dhabi, United Arab Emirates (F.I. Al Hosani, M. Al Mulla, A. Khudhair, B. Aden, F. El Saleh, W. Al Dhaheri, Z. Al Bandar, K. Abou Elkheir, A. Turner, K. Pradeep); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Pringle, L. Kim, H. Pham, N.N. Alami, A.J. Hall, S. Bunga, Y. Tao, J.C. Hunter, D. Nguyen, S. Tong, B.L. Whitaker, L.M. Haynes, A. Curns, S.I. Gerber); Sheikh Khalifa Medical Laboratory, Abu Dhabi (J. Sasse, S. Weber).

Main Article

Table 1

Demographic information, symptom duration, and length of positivity by disease severity among MERS-CoV case-patients, Abu Dhabi, United Arab Emirates, January 1, 2013–May 9, 2014*

Characteristic, N = 65 Asymptomatic, 
n = 23 (35) With mild symptoms, n = 24 (37) With severe symptoms, n = 18 (28) p value†
Sex 0.25
M 16 (70) 13 (54) 14 (78)
F
 7 (30)
 11 (46)
 4 (22)
Age, y, median (IQR) 42 (30–54) 37 (30–43) 60 (40–68)
≤19 0 2 (8) 0
20–39 10 (44) 13 (54) 4 (22)
40–59 10 (44) 9 (38) 5 (28)
≥60
 3 (13)
 0 (0)
 9 (50)
Healthcare personnel <0.001
Yes‡ 12 (52) 17 (71) 2 (11)
No
 11 (48)
 7 (29)
 16 (89)
Symptom duration before hospitalization <0.001
≥8 d NA 1 (4) 1 (6)
4–7 d NA 6 (25) 10 (56)
1–3 d NA 5 (21) 3 (17)
Same day as admission NA 9 (38) 2 (11)
After admission NA 2 (8) 2 (11)
Unknown
 NA
 1 (4)
 0
Length of PCR positivity, d 0.03
<7 15 (65) 12 (50) 12 (67)
7–14 7 (30) 3 (13) 1 (6)
>14 1 (4) 9 (38) 5 (28)

*Values are no. (%) patients except as indicated. Percentages might not sum to 100% due to rounding. IQR, interquartile range; MERS-CoV, Middle East respiratory syndrome coronavirus; NA, not applicable.
†Mantel-Haenszel χ2 test.
‡Healthcare personnel were not necessarily part of a healthcare-associated cluster.

Main Article

1These authors contributed equally to this article and share first authorship.

Page created: June 14, 2016
Page updated: June 14, 2016
Page reviewed: June 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external